These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 18621671)

  • 1. Drug target identification using side-effect similarity.
    Campillos M; Kuhn M; Gavin AC; Jensen LJ; Bork P
    Science; 2008 Jul; 321(5886):263-6. PubMed ID: 18621671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting new molecular targets for known drugs.
    Keiser MJ; Setola V; Irwin JJ; Laggner C; Abbas AI; Hufeisen SJ; Jensen NH; Kuijer MB; Matos RC; Tran TB; Whaley R; Glennon RA; Hert J; Thomas KL; Edwards DD; Shoichet BK; Roth BL
    Nature; 2009 Nov; 462(7270):175-81. PubMed ID: 19881490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemical basis of pharmacology.
    Keiser MJ; Irwin JJ; Shoichet BK
    Biochemistry; 2010 Dec; 49(48):10267-76. PubMed ID: 21058655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities.
    Matthews EJ; Kruhlak NL; Benz RD; Aragonés Sabaté D; Marchant CA; Contrera JF
    Regul Toxicol Pharmacol; 2009 Jun; 54(1):43-65. PubMed ID: 19422100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug target prediction using adverse event report systems: a pharmacogenomic approach.
    Takarabe M; Kotera M; Nishimura Y; Goto S; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i611-i618. PubMed ID: 22962489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the associations between drug side-effects and therapeutic indications.
    Wang F; Zhang P; Cao N; Hu J; Sorrentino R
    J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive assessment of ADMET risks in drug discovery.
    Wang J
    Curr Pharm Des; 2009; 15(19):2195-219. PubMed ID: 19601823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STITCH: interaction networks of chemicals and proteins.
    Kuhn M; von Mering C; Campillos M; Jensen LJ; Bork P
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D684-8. PubMed ID: 18084021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse similarity and reliable negative samples for drug side-effect prediction.
    Zheng Y; Peng H; Ghosh S; Lan C; Li J
    BMC Bioinformatics; 2019 Feb; 19(Suppl 13):554. PubMed ID: 30717666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inferring protein domains associated with drug side effects based on drug-target interaction network.
    Iwata H; Mizutani S; Tabei Y; Kotera M; Goto S; Yamanishi Y
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S18. PubMed ID: 24565527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A side effect resource to capture phenotypic effects of drugs.
    Kuhn M; Campillos M; Letunic I; Jensen LJ; Bork P
    Mol Syst Biol; 2010; 6():343. PubMed ID: 20087340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.
    Chartier M; Morency LP; Zylber MI; Najmanovich RJ
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):18. PubMed ID: 28449705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting drugs side effects based on chemical-chemical interactions and protein-chemical interactions.
    Chen L; Huang T; Zhang J; Zheng MY; Feng KY; Cai YD; Chou KC
    Biomed Res Int; 2013; 2013():485034. PubMed ID: 24078917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models.
    Yao ZJ; Dong J; Che YJ; Zhu MF; Wen M; Wang NN; Wang S; Lu AP; Cao DS
    J Comput Aided Mol Des; 2016 May; 30(5):413-24. PubMed ID: 27167132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs.
    Hosomi K; Fujimoto M; Ushio K; Mao L; Kato J; Takada M
    PLoS One; 2018; 13(10):e0204648. PubMed ID: 30300381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of drug-induced effect patterns to link structure and side effects of medicines.
    Fliri AF; Loging WT; Thadeio PF; Volkmann RA
    Nat Chem Biol; 2005 Dec; 1(7):389-97. PubMed ID: 16370374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting drug side-effects by chemical systems biology.
    Tatonetti NP; Liu T; Altman RB
    Genome Biol; 2009; 10(9):238. PubMed ID: 19723347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.